Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides.
about
Recognition of Staphylococcus aureus by the innate immune system.Antibacterial action of structurally diverse cationic peptides on gram-positive bacteriaCapsule polysaccharide mediates bacterial resistance to antimicrobial peptidesExoproteome of Staphylococcus aureus reveals putative determinants of nasal carriageReduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implicationsSkin microbiota: a source of disease or defence?Epithelial antimicrobial peptides in host defense against infectionEvasion of Neutrophil Killing by Staphylococcus aureusAntimicrobial Mechanisms of Macrophages and the Immune Evasion Strategies of Staphylococcus aureusStaphylococcal manipulation of host immune responsesStrategies and molecular tools to fight antimicrobial resistance: resistome, transcriptome, and antimicrobial peptidesAntibiotic development challenges: the various mechanisms of action of antimicrobial peptides and of bacterial resistanceEnhancing the stress responses of probiotics for a lifestyle from gut to product and back againMolecular basis of Staphylococcus epidermidis infectionsAntimicrobial proteins in intestine and inflammatory bowel diseasesNeutrophils in innate host defense against Staphylococcus aureus infectionsModulation of Staphylococcus aureus spreading by waterStaphylococcus aureus Colonization of the Mouse Gastrointestinal Tract Is Modulated by Wall Teichoic Acid, Capsule, and Surface ProteinsThe solution structures of the human beta-defensins lead to a better understanding of the potent bactericidal activity of HBD3 against Staphylococcus aureusSolution structure, antibacterial activity, and expression profile ofManduca sextamoricinCrystal structure of DltA. Implications for the reaction mechanism of non-ribosomal peptide synthetase adenylation domainsSynthesis of CDP-Activated Ribitol for Teichoic Acid Precursors in Streptococcus pneumoniaeLantibiotic resistance.High-resolution structures of the D-alanyl carrier protein (Dcp) DltC from Bacillus subtilis reveal equivalent conformations of apo- and holo-formsAntimicrobial Activity of Cationic Antimicrobial Peptides against Gram-Positives: Current Progress Made in Understanding the Mode of Action and the Response of BacteriaAntimicrobial Peptides Targeting Gram-Positive BacteriaStaphylococcal adaptation to diverse physiologic niches: an overview of transcriptomic and phenotypic changes in different biological environmentsStaphylococcus epidermidis--the 'accidental' pathogenGenome-Wide Identification of Antimicrobial Intrinsic Resistance Determinants in Staphylococcus aureusThe Staphylococcus aureus peptidoglycan protects mice against the pathogen and eradicates experimentally induced infectionProton-binding capacity of Staphylococcus aureus wall teichoic acid and its role in controlling autolysin activityNovel inhibitors of Staphylococcus aureus virulence gene expression and biofilm formationBiosynthesis of the glycolipid anchor in lipoteichoic acid of Staphylococcus aureus RN4220: role of YpfP, the diglucosyldiacylglycerol synthaseImmunity to the bacteriocin sublancin 168 Is determined by the SunI (YolF) protein of Bacillus subtilisIdentification and characterization of a periplasmic aminoacyl-phosphatidylglycerol hydrolase responsible for Pseudomonas aeruginosa lipid homeostasisBiohybrid polymer-antimicrobial peptide medium against Enterococcus faecalisL-Rhamnosylation of Listeria monocytogenes Wall Teichoic Acids Promotes Resistance to Antimicrobial Peptides by Delaying Interaction with the MembraneStructure and Mechanism of Staphylococcus aureus TarS, the Wall Teichoic Acid β-glycosyltransferase Involved in Methicillin ResistanceWall teichoic acids mediate increased virulence in Staphylococcus aureus.Dermcidin-derived peptides show a different mode of action than the cathelicidin LL-37 against Staphylococcus aureus.
P2860
Q24530569-C61EA702-30C9-419D-8381-A2A932A05D87Q24550625-53A59563-FA2C-44E7-8053-9A3B6B0EC88FQ24559990-2AD3A669-2DEC-4CA8-84D3-2944B11341CAQ24628406-90F05097-3FBB-44C6-A475-AD41A6B98937Q24646677-06D4FF06-5BD0-4A56-BD7B-AB72DB5776DCQ24651518-F13D2D31-468F-411E-8023-F939EF376A5EQ24791605-2EBE66A5-487D-4527-A571-C284DAD4E974Q26752941-0AF7D293-4647-4C63-9C3E-57CC674843FDQ26774998-3CE78613-E08F-487E-936E-42201D34DD7EQ26798461-65ED4630-20F2-40AC-82D6-81A11E88B9C5Q26861137-74F7338B-B6BB-43DE-9C92-ECFD7CADE578Q26991811-3F630961-07E5-4125-9A04-7E5C88F40C36Q27002713-A569EC0E-9035-4FB6-9FE3-F90E9C35CFBCQ27013870-6D74C2DB-AA56-45A0-85FB-0218E04A7F1BQ27023239-224AA98E-58CE-44B4-AE57-7064CC117FD8Q27024628-8F7909A6-AE66-47A6-BAEC-9A9D6D8C0011Q27318129-0D0993FE-5FED-4F62-AA3D-53C4529F7790Q27318407-0F32144D-0E55-47B1-B6E6-247FFCFC2950Q27636772-BA9C99E2-C4B3-419D-A098-B15958D58836Q27649831-72EABE32-E4D8-4D04-B1DF-A42674519DD9Q27652079-D8E3E0A3-0BAC-471F-BDE5-E8A3901C09AFQ27653131-CCAE086A-9CAB-41F0-87FB-F83BB0DC768DQ27692563-CEC1B0F7-15AC-48FC-B2EF-B35D368823CAQ27701584-CA869952-936A-4BE2-B99F-DC93D7E0810FQ28072687-B0890CB1-3F53-418D-8F93-D14191625327Q28077888-A8CDF56F-FDAD-4893-941E-7E19CD3A539EQ28087340-2C8E4A6D-DD12-4BEB-A11E-FE399CBB75F9Q28252268-77529795-86F7-4047-8F74-DD03EE6AD98BQ28354064-F8BD7F42-6F0C-431A-A670-F4EF2B854964Q28478213-DAF0DFDC-4BBF-4EDF-88A6-EE0BEFC7B9E2Q28481453-15C91EE2-73F3-48D8-8317-1EAC6C23C0A0Q28484413-A3FC5672-46AC-4577-A05F-EA49B0247C4BQ28485594-45286D1D-85A1-44C2-A477-0E81EDD6AD24Q28488914-FC4E27ED-7FAB-4FDE-A002-B18F81190EBEQ28492987-C69C944B-2635-47FC-A920-1127B96B6FE8Q28543531-C9387F28-E757-4295-92AF-D30718273DB8Q28547427-72D2DA38-E869-408F-BBF1-C3A35AB9705BQ28555021-D5FB84A8-F79C-415A-A9E0-CFE90CBEA4A2Q30397807-B1EA9251-6E96-4052-8E82-35EBCB21174FQ30484849-0744B4DE-68CE-48EA-B16A-E08755EE9228
P2860
Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Inactivation of the dlt operon ...... other antimicrobial peptides.
@ast
Inactivation of the dlt operon ...... other antimicrobial peptides.
@en
type
label
Inactivation of the dlt operon ...... other antimicrobial peptides.
@ast
Inactivation of the dlt operon ...... other antimicrobial peptides.
@en
prefLabel
Inactivation of the dlt operon ...... other antimicrobial peptides.
@ast
Inactivation of the dlt operon ...... other antimicrobial peptides.
@en
P2093
P2860
P356
P1476
Inactivation of the dlt operon ...... other antimicrobial peptides.
@en
P2093
P2860
P304
P356
10.1074/JBC.274.13.8405
P407
P577
1999-03-01T00:00:00Z